Results 1 to 10 of about 13,834,757 (208)

Efficacy of natural killer T and gammadelta T cells in mesothelin-targeted immunotherapy of pancreatic cancer [PDF]

open access: yesFrontiers in Immunology
Current pancreatic cancer immunotherapy focused on alphabeta (αβ) T cells, either through CD3-engaged bispecific antibodies or CAR-T. Despite their promise, dose-limited toxicity (DLT) remains a challenge in clinical practice. In light of these concerns,
Yuankui Zhu   +14 more
doaj   +4 more sources

NK cells and gammadelta T cells mediate resistance to polyomavirus-induced tumors. [PDF]

open access: yesPLoS Pathogens, 2010
NK and gammadelta T cells can eliminate tumor cells in many experimental models, but their effect on the development of tumors caused by virus infections in vivo is not known.
Rabinarayan Mishra   +3 more
doaj   +2 more sources

DDIT4 upregulation associates with gammadelta T Cells dysfunction in ART-suppressed people living with HIV-1 [PDF]

open access: yesBMC Infectious Diseases
Background Antiretroviral therapy (ART) effectively suppresses HIV-1 replication, yet T cell dysfunction persists in ART-suppressed people living with HIV-1 (PLWH).
Haihan Wang   +12 more
doaj   +2 more sources

Expansion of Gammadelta T Cells from Cord Blood: A Therapeutical Possibility [PDF]

open access: yesStem Cells International, 2018
Gammadelta (γδ) T cells are found in both blood and tissues and have antiviral and antitumor properties. The frequency of γδ T cells in umbilical cord blood (UCB) is low, and the majority express δ1, in contrast to blood, whereas the main subset is δ2γ9 ...
Sofia Berglund   +4 more
doaj   +2 more sources

Monitoring circulating gammadelta T cells in cancer patients to optimize gammadelta T cell-based immunotherapy

open access: yesFrontiers in Immunology, 2014
The success of gammadelta (gd) T cell-based immunotherapy, where the cytotoxic activity of circulating gd T lymphocytes is activated by nitrogen-containing bisphosphonates (n-BP), or possibly by bispecific antibodies or the combination of both, requires ...
Hans-Heinrich eOberg   +7 more
doaj   +2 more sources

Obesity and cancer: the gammadelta T cell link

open access: yesExploration of Immunology, 2022
Obesity has become a worldwide scourge, affecting more than 10% of adults worldwide. While widely recognized to be associated with increased incidence of medical conditions such as diabetes mellitus and atherosclerosis, obesity also accounts for 9% of ...
Ilan Bank
doaj   +2 more sources

Generation and preclinical characterization of a novel bispecific CD19-TCRgammadelta antibody for the treatment of B cell acute lymphoblastic leukemia [PDF]

open access: yesFrontiers in Immunology
IntroductionB-cell acute lymphoblastic leukemia (B-ALL) is characterized by the clonal expansion of immature lymphoblastic cells. Treating patients with disease relapse is challenging, especially after allogeneic stem cell transplantation (aSCT ...
Joseph Kauer   +22 more
doaj   +2 more sources

Ageing and latent CMV infection impact on maturation, differentiation and exhaustion profiles of T-cell receptor gammadelta T-cells. [PDF]

open access: yesSci Rep, 2017
Kallemeijn MJ   +7 more
europepmc   +2 more sources

Gammadelta T cells are reduced and rendered unresponsive by hyperglycemia and chronic TNFalpha in mouse models of obesity and metabolic disease. [PDF]

open access: yesPLoS ONE, 2010
Epithelial cells provide an initial line of defense against damage and pathogens in barrier tissues such as the skin; however this balance is disrupted in obesity and metabolic disease.
Kristen R Taylor   +3 more
doaj   +1 more source

Potential use of [gammadelta] T cell-based vaccines in cancer immunotherapy

open access: yesFrontiers in Immunology, 2014
Immunotherapy is a fast advancing methodology involving one of two approaches: 1) compounds targeting immune checkpoints, and 2) cellular immunomodulators.
Mohd Wajid A. Khan   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy